ArticleCase reports in nephrology and dialysis
Efficacy and Safety of Semaglutide, a Glucagon-Like Peptide-1 Receptor Agonist in Real-Life: A Case Series of Patients in Maintenance Incremental Hemodialysis.
José C De la Flor et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
7 papers cite it
pooled itcites it